Brandywine Global Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$140M Buy
427,722
+57,626
+16% +$18.3M 0.94% 21
2025
Q3
$104M Sell
370,096
-6,104
-2% -$1.77M 0.72% 29
2025
Q2
$105M Buy
376,200
+312,480
+490% +$88.5M 0.74% 30
2025
Q1
$19.9M Buy
63,720
+11,924
+23% +$3.52M 0.14% 165
2024
Q4
$13.5M Sell
51,796
-81
-0.2% -$24K 0.1% 205
2024
Q3
$16.8M Sell
51,877
-281,990
-84% -$92.2M 0.11% 186
2024
Q2
$104M Buy
333,867
+11,468
+4% +$3.37M 0.78% 27
2024
Q1
$91.7M Sell
322,399
-2,641
-0.8% -$773K 0.66% 35
2023
Q4
$93.6M Sell
325,040
-49,793
-13% -$13.6M 0.75% 24
2023
Q3
$101M Sell
374,833
-56,253
-13% -$14M 0.88% 18
2023
Q2
$95.7M Sell
431,086
-130,029
-23% -$30.2M 0.8% 25
2023
Q1
$136M Buy
561,115
+214,512
+62% +$52.7M 1.1% 15
2022
Q4
$91M Buy
346,603
+42,820
+14% +$11.5M 0.71% 31
2022
Q3
$68.5M Sell
303,783
-32,394
-10% -$7.85M 0.64% 36
2022
Q2
$81.8M Buy
336,177
+109,165
+48% +$26.8M 0.71% 28
2022
Q1
$54.9M Buy
227,012
+201,232
+781% +$46.2M 0.4% 71
2021
Q4
$5.8M Sell
25,780
-179
-0.7% -$37.8K 0.04% 377
2021
Q3
$5.52M Sell
25,959
-466
-2% -$107K 0.04% 380
2021
Q2
$6.44M Sell
26,425
-468,967
-95% -$115M 0.05% 371
2021
Q1
$123M Sell
495,392
-30,953
-6% -$7.39M 0.93% 17
2020
Q4
$121M Sell
526,345
-779
-0.1% -$180K 1% 16
2020
Q3
$134M Sell
527,124
-84,917
-14% -$21M 1.32% 14
2020
Q2
$144M Sell
612,041
-20,645
-3% -$4.71M 1.47% 13
2020
Q1
$128M Sell
632,686
-10,253
-2% -$2.24M 1.53% 14
2019
Q4
$154M Sell
642,939
-3,936
-0.6% -$868K 1.09% 19
2019
Q3
$125M Sell
646,875
-58,725
-8% -$11.3M 0.92% 20
2019
Q2
$130M Buy
705,600
+4,511
+0.6% +$808K 0.9% 23
2019
Q1
$133M Sell
701,089
-79,218
-10% -$15.1M 0.92% 24
2018
Q4
$152M Buy
780,307
+19,528
+3% +$3.81M 1.12% 17
2018
Q3
$158M Sell
760,779
-34,205
-4% -$6.74M 0.98% 20
2018
Q2
$147M Buy
794,984
+51,889
+7% +$9.18M 0.94% 22
2018
Q1
$127M Buy
743,095
+13,945
+2% +$2.56M 0.8% 27
2017
Q4
$127M Buy
729,150
+103,941
+17% +$18.4M 0.76% 30
2017
Q3
$117M Sell
625,209
-21,770
-3% -$3.86M 0.74% 31
2017
Q2
$111M Sell
646,979
-12,580
-2% -$2.05M 0.71% 31
2017
Q1
$108M Buy
659,559
+9,654
+1% +$1.6M 0.68% 31
2016
Q4
$95M Sell
649,905
-23,822
-4% -$3.59M 0.6% 38
2016
Q3
$112M Sell
673,727
-15,099
-2% -$2.55M 0.74% 29
2016
Q2
$105M Sell
688,826
-16,910
-2% -$2.63M 0.71% 33
2016
Q1
$106M Sell
705,736
-7,488
-1% -$1.11M 0.69% 38
2015
Q4
$116M Buy
713,224
+13,521
+2% +$2.13M 0.74% 29
2015
Q3
$96.8M Buy
699,703
+114,543
+20% +$18.1M 0.63% 34
2015
Q2
$89.8M Buy
585,160
+20,600
+4% +$3.3M 0.56% 41
2015
Q1
$90.2M Buy
564,560
+12,570
+2% +$1.98M 0.58% 38
2014
Q4
$87.9M Buy
551,990
+46,060
+9% +$7.18M 0.59% 39
2014
Q3
$71.1M Buy
505,930
+88,950
+21% +$11.6M 0.52% 47
2014
Q2
$49.4M Buy
416,980
+56,290
+16% +$6.52M 0.39% 55
2014
Q1
$44.5M Buy
360,690
+1,570
+0.4% +$190K 0.39% 55
2013
Q4
$41M Buy
359,120
+4,190
+1% +$477K 0.38% 56
2013
Q3
$39.7M Buy
354,930
+3,283
+0.9% +$356K 0.4% 59
2013
Q2
$34.7M Buy
+351,647
New +$36.5M 0.36% 61

Other funds holding AMGN

Brandywine Global Investment Management's AMGN Position: Q4 2025 in Review

Brandywine Global Investment Management increased its Amgen (AMGN) stake by 16% in Q4 2025, buying an estimated $18.3M and bringing the position to 427,722 shares worth $140M. The position accounts for 0.94% of the portfolio, ranked #21.

Brandywine Global Investment Management first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $158M in Q3 2018. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Brandywine Global Investment Management held 427,722 shares of Amgen worth $140M as of Q4 2025.
  • Brandywine Global Investment Management bought 57,626 Amgen shares in Q4 2025, an estimated $18.3M.
  • Amgen made up 0.94% of Brandywine Global Investment Management's portfolio in Q4 2025, its #21 holding.
  • Brandywine Global Investment Management first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Brandywine Global Investment Management's Amgen position peaked at $158M in Q3 2018.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.